V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 20215467 | 20130422 | 178.5 | 76.2 | Palliative (P) | 2020-01-09 | 2020-01-15 | Sorafenib | 02 | null | SORAFENIB | 101059272 |
| 20215469 | 20130423 | 1.66 | 84.6 | Palliative (P) | 2021-06-24 | 2021-09-04 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100329451 |
| 20215471 | 20130424 | 1.78 | 55 | Palliative (P) | 2018-12-28 | 2019-07-02 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101863133 |
| 20215472 | 20130425 | 1.73 | 70.6 | Curative (C) | 2015-09-10 | 2016-05-17 | Sorafenib | N | N | SORAFENIB | 100895464 |
| 20215475 | 20130426 | null | 48 | Palliative (P) | 2019-06-02 | 2019-09-10 | Oxaliplatin + Raltitrexed | Y | N | TRIAL | 101253268 |
| 20215477 | 20130427 | 1.61 | 80.3 | Palliative (P) | 2018-07-11 | 2018-08-01 | Capecitabine 35days + RT | N | N | CAPECITABINE + RT | 101631356 |
| 20215481 | 20130428 | 1.7 | 59 | Palliative (P) | 2018-11-04 | 2018-11-20 | Oxaliplatin + Raltitrexed | Y | null | OXALIPLATIN + RALTITREXED | 101381884 |
| 20215483 | 20130429 | 1.7 | 61 | Neo-adjuvant (N) | 2019-03-06 | 2019-03-06 | Cetuximab + FOLFIRI cycle 2 onwards | 2 | Y | CETUXIMAB + IRINOTECAN + MDG | 101002288 |
| 20215484 | 20130430 | 1.62 | 101.1 | null | 2018-01-01 | 2018-01-12 | EOX | 02 | null | CETUXIMAB + IRINOTECAN + MDG | 100994397 |
| 20215487 | 20130431 | 1.75 | 64 | Palliative (P) | 2017-09-20 | 2017-09-23 | Trial Unspecified | N | N | TRIAL | 100760825 |
| 20215488 | 20130432 | 1.59 | 104 | Palliative (P) | 2017-01-23 | 2017-01-24 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100712956 |
| 20215490 | 20130433 | 1.88 | 60.8 | Palliative (P) | 2017-02-02 | 2017-05-01 | CAPECITABINE + RT | 02 | N | CAPECITABINE + RT | 101320273 |
| 20215491 | 20130434 | 1.85 | 73.4 | Palliative (P) | null | 2020-11-08 | Trial Unspecified | Y | N | TRIAL | 100747289 |
| 20215493 | 20130435 | 1.79 | 86.8 | null | 2018-05-06 | 2018-05-06 | Trial Unspecified | 1 | null | CETUXIMAB + IRINOTECAN + MDG | 101329471 |
| 20215494 | 20130436 | 1.82 | 83.5 | Palliative (P) | 2016-08-24 | 2016-09-15 | Trial Unspecified | Y | N | TRIAL | 101402901 |
| 20215498 | 20130437 | 1.56 | 86.9 | Palliative (P) | 2018-05-08 | 2018-06-03 | Trial Unspecified | 02 | N | TRIAL | 100514765 |
| 20215499 | 20130438 | 0 | 71 | Palliative (P) | 2021-10-16 | 2021-10-16 | Trial Unspecified | 2 | N | TRIAL | 100580590 |
| 20215503 | 20130439 | 1.75 | 54.3 | Palliative (P) | 2019-03-09 | 2019-06-11 | Sorafenib | 02 | null | SORAFENIB | 100773422 |
| 20215505 | 20130440 | 1.75 | 80.2 | Palliative (P) | 2017-01-31 | 2017-01-31 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101360998 |
| 20215507 | 20130441 | 1.59 | 79 | Palliative (P) | 2017-11-28 | 2017-12-24 | Sorafenib | 99 | N | CAPECITABINE + RT | 101337926 |
| 20215512 | 20130442 | 1.88 | 111 | null | 2020-06-24 | 2020-07-19 | EOX | 02 | Y | EOX | 101304083 |
| 20215513 | 20130443 | 1.88 | 78.8 | Palliative (P) | 2020-02-01 | 2020-02-15 | EOX | 1 | null | TRIAL | 101683326 |
| 20215517 | 20130444 | 1.57 | 65.4 | Palliative (P) | 2019-07-11 | 2019-07-24 | Cetuximab + FLUOROURACIL + OXALIPLATIN | 01 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100155994 |
| 20215521 | 20130445 | 1.64 | 77.6 | Palliative (P) | 2016-05-29 | 2016-06-29 | EOX | 99 | N | EOX | 100810404 |
| 20215523 | 20130446 | 1.5 | 56 | Palliative (P) | 2016-11-09 | 2017-05-25 | EOX | 02 | N | TRIAL | 101113970 |
| 20215525 | 20130447 | 1.6 | 90.6 | Adjuvant (A) | 2019-10-17 | 2019-11-03 | Trial Unspecified | Y | N | TRIAL | 101541250 |
| 20215527 | 20130448 | 1.6 | 91 | Palliative (P) | 2016-07-14 | 2016-07-28 | IRINOTECAN + MDG + PANITUMUMAB | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101021453 |
| 20215528 | 20130449 | 1.63 | 102 | Palliative (P) | 2018-10-02 | 2019-06-22 | EOX | 02 | N | SORAFENIB | 101016726 |
| 20215533 | 20130450 | 1.74 | 70.8 | Neo-adjuvant (N) | 2017-02-10 | 2017-02-17 | Trial Unspecified | 99 | Y | TRIAL | 100072129 |
| 20215534 | 20130451 | 0 | 53.7 | null | 2019-10-06 | 2019-10-16 | EOX | 02 | null | OXALIPLATIN + RALTITREXED | 100896720 |
| 20215538 | 20130452 | 1.72 | 109.8 | Palliative (P) | 2019-08-03 | 2019-08-04 | CAPECITABINE + RT | N | Y | CAPECITABINE + RT | 100290366 |
| 20215539 | 20130453 | 1.7 | 71.1 | Palliative (P) | 2019-01-28 | 2019-01-28 | EOX | N | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101700433 |
| 20215540 | 20130454 | 1.76 | 84.3 | Palliative (P) | 2017-01-19 | 2018-02-15 | EOX | N | N | EOX | 101205920 |
| 20215541 | 20130455 | 1.72 | 112 | Neo-adjuvant (N) | 2017-04-06 | 2017-04-06 | Trial Unspecified | N | N | TRIAL | 101168142 |
| 20215542 | 20130456 | 1.59 | 70 | Neo-adjuvant (N) | 2017-12-10 | 2017-12-10 | Panitumumab + Irinotecan + MdG | Y | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100610274 |
| 20215544 | 20130457 | 1.62 | 93.8 | Palliative (P) | 2019-02-13 | 2019-03-12 | CAPECITABINE + RT | N | N | CAPECITABINE + RT | 100339859 |
| 20215545 | 20130458 | 1.45 | 90.6 | null | 2017-11-20 | 2017-12-21 | Cetuximab + Oxaliplatin + MdG Maint | 02 | null | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101283128 |
| 20215546 | 20130459 | 1.78 | 51.4 | Palliative (P) | 2021-08-04 | 2021-08-05 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100552892 |
| 20215548 | 20130460 | 1.87 | 73.4 | Palliative (P) | 2018-12-19 | 2018-12-23 | EOX | N | N | EOX | 101578864 |
| 20215550 | 20130461 | 1.6 | 79.8 | Palliative (P) | 2018-06-01 | 2019-10-14 | EOX | 02 | N | OXALIPLATIN + RALTITREXED | 100579298 |
| 20215551 | 20130462 | 1.63 | 111.05 | Palliative (P) | 2018-04-29 | 2018-05-01 | CETUXIMAB + IRINOTECAN + MDG | 02 | N | CETUXIMAB + IRINOTECAN + MDG | 101422277 |
| 20215552 | 20130463 | 1.82 | 61 | null | 2017-04-08 | 2017-04-15 | Sorafenib | 02 | N | SORAFENIB | 100215382 |
| 20215553 | 20130464 | 1.69 | 89 | Neo-adjuvant (N) | 2017-09-24 | 2017-09-24 | EOX | 02 | Y | OXALIPLATIN + RALTITREXED | 100430302 |
| 20215554 | 20130465 | 1.78 | 102 | Palliative (P) | null | 2019-05-14 | IRINOTECAN + MDG + PANITUMUMAB | 02 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100541872 |
| 20215556 | 20130466 | 1.55 | 70.6 | null | 2020-10-06 | 2020-10-15 | Cetuximab + Oxaliplatin + MdG Load | 1 | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 101065036 |
| 20215558 | 20130467 | 1.72 | 82.7 | null | 2019-06-14 | 2019-07-20 | Cetuximab + FLUOROURACIL + OXALIPLATIN | N | N | CETUXIMAB + FLUOROURACIL + OXALIPLATIN | 100216702 |
| 20215560 | 20130468 | 1.55 | 88.1 | null | 2017-11-14 | 2017-12-15 | EOX | 02 | null | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 100034229 |
| 20215563 | 20130469 | 1.74 | 98 | Curative (C) | 2019-10-13 | 2019-10-14 | EOX | 99 | N | FLUOROURACIL + IRINOTECAN + PANITUMUMAB | 101600238 |
| 20215565 | 20130470 | 1.84 | 52.9 | Palliative (P) | null | 2017-10-30 | Sorafenib | Y | null | SORAFENIB | 100419319 |
| 20215566 | 20130471 | 1.7 | 76 | Palliative (P) | 2018-08-15 | 2018-08-16 | Sorafenib | 02 | N | SORAFENIB | 100445859 |